Malcolm Brenner - 25 May 2021 Form 4 Insider Report for Allovir, Inc. (KLRS)

Role: Director
Signature: /s/ Brett Hagen, as Attorney-in-Fact
Issuer symbol: KLRS
Transactions as of: 25 May 2021
Net transactions value: $0
Form type: 4
Filing time: 27 May 2021, 16:50:14 UTC
Next filing: 19 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALVR	Common Stock	Gift	$0	-818,663	-100%	$0.000000^*	0	25 May 2021	See Footnote	F1
holding	ALVR	Common Stock						163,732	25 May 2021	See Footnote	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ALVR	Stock Option (Right to Buy)	Award	$0	+22,500		$0.000000	22,500	25 May 2021	Common Stock	22,500	$21.51	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares held by Salt Free LP. On May 25, 2021, Salt Free LP distributed to its limited partners, pro rata and without consideration, 818,663 shares of the Issuer's common stock.The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F2	Shares held by The Malcolm and Cliona Brenner Revocable Trust, of which the Reporting Person is a trustee and settlor. These shares were received in the distribution described in footnote (1) above. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F3	This option shall vest and become exercisable upon the earlier to occur of (i) May 25, 2022 and (ii) the next annual meeting of the Issuer's stockholders.